APC
GOSS icon

Aspire Private Capital’s Gossamer Bio GOSS Stock Holding History

Aspire Private Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200
Closed -$2K – 631
2021
Q4 		$2K Hold
200
– – ﹤0.01% 516
2021
Q3 		$3K Hold
200
– – ﹤0.01% 444
2021
Q2 		$2K Buy
+200
New +$1.73K ﹤0.01% 488

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Aspire Private Capital's GOSS Position: Q1 2022 in Review

Aspire Private Capital sold out of Gossamer Bio (GOSS) in Q1 2022, closing a stake of 200 shares — an estimated $2K sold.

Aspire Private Capital first reported a position in GOSS in Q2 2021 and held it in 3 quarters. The position peaked at $3K in Q3 2021. 141 funds tracked by Wall St. Rank hold GOSS as of Q1 2022.

  • Aspire Private Capital reported no remaining Gossamer Bio position as of Q1 2022 after selling out during the quarter.
  • Aspire Private Capital sold 200 Gossamer Bio shares in Q1 2022, an estimated $2K.
  • Aspire Private Capital first reported a position in Gossamer Bio in Q2 2021 and held it in 3 quarters.
  • Aspire Private Capital's Gossamer Bio position peaked at $3K in Q3 2021.
  • 141 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2022.

Based on Aspire Private Capital's 13F filing for Q1 2022, filed 10 May 2022.